OS Therapies Incorporated

Go to OS Therapies Incorporated Website

$1.70

-0.05 (-2.86%)
Live
Previous Close

$1.75

Day Range

$1.67 - $1.77

Previous Day Range

$1.67 - $1.79

Market Cap

$59.5 million USD

Day Vol.

202885

Previous Day Vol.

309736

Currency

USD

Primary Exchange

None

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Several biotech companies are advancing cancer research with promising clinical milestones, focusing on innovative immunotherapies and targeted treatments amid rising cancer incidence and potential research funding challenges.

Related tickers: ONCY, ZLAB, GOVX, GOVXW, OSTX, SLS.

Read Full Article

Analysts forecast the global oncology drug market to exceed $900 billion by 2034, with biotech firms like Oncolytics, Teva, Citius, ADC Therapeutics, and OS Therapies driving cancer treatment innovation amid potential NCI funding cuts.

Related tickers: ONCY, TEVA, CTOR, ADCT, OSTX.

Read Full Article
Trending Tickers

Please sign in to view